Epizyme, Inc.

JPMORGAN CHASE & CO

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/11/2022

Shares

5,001

Value ($000)

7

Weight

0.0%

2014 Q1 - 2022 Q2 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/11/2022	7	0.0%	5,001	6/30/2022
2022 Q1	5/11/2022	284	0.0%	246,910	3/31/2022
2021 Q4	2/11/2022	517	0.0%	206,768	12/31/2021
2021 Q3	11/12/2021	1,390	0.0%	271,421	9/30/2021
2021 Q2	8/12/2021	1,930	0.0%	232,191	6/30/2021
2021 Q1	5/12/2021	2,118	0.0%	243,238	3/31/2021
2020 Q4	2/19/2021	2,900	0.0%	267,013	12/31/2020
2020 Q3	11/12/2020	3,375	0.0%	280,576	9/30/2020
2020 Q2	8/11/2020	6,624	0.0%	412,422	6/30/2020
2020 Q1	5/12/2020	4,440	0.0%	286,284	3/31/2020
2019 Q4	2/11/2020	10,809	0.0%	439,403	12/31/2019
2014 Q1	5/15/2014	13,531	0.0%	594,241	3/31/2014